University Medical Center Hamburg-Eppendorf, Institute for Sex Research and Forensic Psychiatry
Welcome,         Profile    Billing    Logout  
 1 Trial 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Briken, Peer
Mi Bridge, NCT06133595: - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children

Recruiting
N/A
60
Europe, RoW
Behavioral: MiBridge
Karolinska Institutet, Centre for Psychiatry Research, Region Stockholm, Sweden, Linköping University, Sweden, Universitat Jaume I, Spain, Protect Children Organisation, Finland, National Institute of Mental Health, Czech Republic, Academy of the Police Force, Bratislava, Slovakia, Universitätsklinikum Hamburg-Eppendorf
Child Sexual Abuse, Pedophilia
10/24
10/24
ReDirection, NCT06133569: - Self Help Program for Individuals with Sexual Interest in Children

Recruiting
N/A
60
Europe, RoW
ReDirection
Karolinska Institutet, Centre for Psychiatry Research, Region Stockholm, Sweden, Linköping University, Sweden, Universitat Jaume I, Spain, Protect Children Organisation, Finland, National Institute of Mental Health, Czech Republic, Academy of the Police Force, Bratislava, Slovakia, Universitätsklinikum Hamburg-Eppendorf
Child Abuse Sexual, Pedophilia
10/24
10/24
NCT05831657: Prevent It 2.0/PRIORITY - an ICBT to Reduce the Risk of Committing Child Sexual Abuse

Active, not recruiting
N/A
420
Europe
Prevent It 2.0, Waitlist
Karolinska Institutet, The Royal Ottawa Mental Health Centre, Johns Hopkins Bloomberg School of Public Health, Universitätsklinikum Hamburg-Eppendorf, Universidade do Porto
Pedophilia
10/24
01/25
Köhler, Andreas
ADAPTlate, NCT04565054 / 2019-001488-60: Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

Recruiting
3
1260
Europe
Abemaciclib 50 MG; 150mg 1-0-1 per os, Verzenios
West German Study Group, Eli Lilly and Company, Genomic Health®, Inc.
Breast Cancer Female
08/26
03/28
PLATON, NCT04484636: - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

Completed
N/A
400
Europe
FoundationOne®CDx and FoundationOne®Liquid
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Roche Pharma AG
Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer, Pancreatic Cancer, Oesophageal Cancer, Stomach Cancer
08/24
08/24

Active, not recruiting
N/A
1000
Europe
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer, Pancreatic Cancer, Oesophageal Cancer, Stomach Cancer
05/32
05/32

Download Options